PT - JOURNAL ARTICLE AU - Liu, Yang AU - Tang, Julian W AU - Lam, Tommy TY TI - Transmission Dynamics of the COVID-19 Epidemics in England AID - 10.1101/2020.06.30.20143743 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.30.20143743 4099 - http://medrxiv.org/content/early/2020/08/01/2020.06.30.20143743.short 4100 - http://medrxiv.org/content/early/2020/08/01/2020.06.30.20143743.full AB - The ongoing COVID-19 pandemic has caused a tremendous health burden and impact on the world economy. As one of the European countries experiencing one of the worst COVID-19 epidemics, the UK government at the end of March 2020 implemented the biggest lockdown of society during peacetime in British history, aiming to contain the rapid spread of the virus. While the lockdown has been maintained for seven weeks in UK, the effectiveness of the control measures in suppressing the transmission of the disease remains incompletely understood. Here we applied a Bayesian SEIR (susceptible-exposed-infected-removed) epidemiological model to rebuild the local transmission dynamics of the spread of COVID-19 in nine regions of England. We found that the basic reproduction number (R0) in England is relatively high compared with China. Our estimation of the temporally varying effective reproduction number (Rt) suggests that the control measures, especially the forceful lockdown, were effective to reduce the transmissibility and curb the COVID-19 epidemic. Although the overall incidence rate in the UK has declined, our forecasting highlights the possibility of a second wave of the disease in several regions, which may be currently underway in one of the cities there (e.g. Leicester, East Midlands). This study enhances our understanding of the current outbreak and effectiveness of control measures in the UK.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYang Liu was supported by a Cambridge International Scholarship from the Cambridge Commonwealth, European and International Trust. Tommy TY Lam was supported by The National Natural Science Foundation of China Excellent Young Scientists Fund (Hong Kong and Macau) (31922087).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Since no individual patient's data is identifiable in this study, the ethical approval or individual consent is not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is publicly available.